We used a deer mouse (Peromyscus maniculatus) infection model to test the protective efficacy of genetic vaccine candidates for Sin Nombre (SN) virus that were known to provoke immunological responses in BALB/c mice (Bharadwaj et al., Vaccine 17, 2836–2843, 1999). Protective epitopes were localized in each of four overlapping cDNA fragments that encoded portions of the SN virus G1 glycoprotein antigen; the nucleocapsid gene also was protective. The protective efficacy of glycoprotein gene fragments correlated with splenocyte proliferation in the presence of cognate antigen, but none induced neutralizing antibodies. Genetic vaccines against SN virus can protect outbred deer mice from infection even in the absence of a neutralizing antibody response.
ArikawaJ.,
LapenotiereH. F.,
Iacono-ConnorsL.,
WangM. L.,
SchmaljohnC. S.1990; Coding properties of the S and the M genome segments of Sapporo rat virus: comparison to other causative agents of hemorrhagic fever with renal syndrome. Virology 176:114–125
BharadwajM.,
BottenJ.,
Torrez-MartinezN.,
HjelleB.1997; Rio Mamore virus: genetic characterization of a newly recognized hantavirus of the pygmy rice rat, Oligoryzomys microtis , from Bolivia. American Journal of Tropical Medicine and Hygiene 57:368–374
BharadwajM.,
LyonsC. R.,
WortmanI. A.,
HjelleB.1999; Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 17:2836–2843
BottenJ.,
MirowskyK.,
KusewittD.,
BharadwajM.,
YeeJ.,
RicciR.,
FeddersenR. M.,
HjelleB.2000a; Experimental infection model for Sin Nombre hantavirus in the deer mouse ( Peromyscus maniculatus ). Proceedings of the National Academy of Sciences, USA 97:10578–10583
BottenJ.,
NofchisseyR.,
AhernH.,
Rodriguez-MoranP.,
WortmanI. A.,
GoadeD.,
YatesT.,
HjelleB.2000b; Outdoor facility for quarantine of wild rodents infected with hantavirus. Journal of Mammalogy 81:250–259
BradfordM.1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
Centers for Disease Control & Prevention1994; Laboratory management of agents associated with hantavirus pulmonary syndrome: interim biosafety guidelines. Morbidity and Mortality Weekly Report 43:1–7
ChildsJ. E.,
KsiazekT. G.,
SpiropoulouC. F.,
KrebsJ. W.,
MorzunovS.,
MaupinG. O.,
GageK. L.,
RollinP. E.,
SariskyJ.,
EnscoreR. E.1994; Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. Journal of Infectious Diseases 169:1271–1280
ChuY. K.,
JenningsG. B.,
SchmaljohnC. S.1995; A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. Journal of Virology 69:6417–6423
EbiharaH.,
YoshimatsuK.,
OginoM.,
ArakiK.,
AmiY.,
KariwaH.,
TakashimaI.,
LiD.,
ArikawaJ.2000; Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. Journal of Virology 74:9245–9255
EnriaD.,
PadulaP.,
SeguraE. L.,
PiniN.,
EdelsteinA.,
PosseC. R.,
WeissenbacherM. C.1996; Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina (Buenos Aires) 56:709–711
HjelleB.,
Chavez-GilesF.,
Torrez-MartinezN.,
YamadaT.,
SariskyJ.,
AscherM.,
JenisonS.1994; Dominant glycoprotein epitope of Four Corners hantavirus is conserved across a wide geographical area. Journal of General Virology 75:2881–2888
HooperJ. W.,
KamrudK. I.,
ElghF.,
CusterD.,
SchmaljohnC. S.1999; DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 255:269–278
LoberC.,
AnheierB.,
LindowS.,
KlenkH. D.,
FeldmannH.2001; The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 289:224–229
McClainD. J.,
SummersP. L.,
HarrisonS. A.,
SchmaljohnA. L.,
SchmaljohnC. S.2000; Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. Journal of Medical Virology 60:77–85
MillsJ. N.,
YatesT. L.,
ChildsJ. E.,
ParmenterR. R.,
KsiazekT. G.,
RollinP. E.,
PetersC. J.1995; Guidelines for working with rodents potentially infected with hantavirus. Journal of Mammalogy 76:716–722
SchmaljohnC. S.1996; Bunyaviridae : the viruses and their replication. In Fields Virology pp 1447–1471 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott–Raven;
SchmaljohnC. S.,
HastyS. E.,
DalrympleJ. M.,
LeducJ. W.,
LeeH. W.,
von BonsdorffC. H.,
Brummer-KorvenkontioM.,
VaheriA.,
TsaiT. F.,
RegneryH. L.1985; Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227:1041–1044
SchmaljohnC. S.,
ChuY. K.,
SchmaljohnA. L.,
DalrympleJ. M.1990; Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. Journal of Virology 64:3162–3170
SchmaljohnC. S.,
HastyS. E.,
DalrympleJ. M.1992; Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine 10:10–13
UlrichR.,
LundkvistA.,
MeiselH.,
KoletzkiD.,
SjolanderK. B.,
GelderblomH. R.,
BorisovaG.,
SchnitzlerP.,
DaraiG.,
KrugerD. H.1998; Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine 16:272–280
WangM. W.,
PennockD. G.,
SpikK. W.,
SchmaljohnC. S.1992; Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus. Virology 192:757–766
YamadaT.,
HjelleB.,
LanziR.,
MorrisC.,
AndersonB.,
JenisonS.1995; Antibody responses to Four Corners hantavirus infections in the deer mouse ( Peromyscus maniculatus ): identification of an immunodominant region of the viral nucleocapsid protein. Journal of Virology 69:1939–1943
YoshimatsuK.,
YooY. C.,
YoshidaR.,
IshiharaC.,
AzumaI.,
ArikawaJ.1993; Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Archives of Virology 130:365–376